Optiver Holding’s ResMed RMD Stock Holding History

Optiver Holding’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-145	Closed	-$33.2K	–	1546
2024 Q4	$33.2K	Buy	+145	New	+$34.9K	﹤0.01%	642

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Optiver Holding's RMD Position: Q1 2025 in Review

Optiver Holding sold out of ResMed (RMD) in Q1 2025, closing a stake of 145 shares — an estimated $33.2K sold.

Optiver Holding first reported a position in RMD in Q4 2024 and held it in 1 quarter. The position peaked at $33.2K in Q4 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Optiver Holding reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Optiver Holding sold 145 ResMed shares in Q1 2025, an estimated $33.2K.
Optiver Holding first reported a position in ResMed in Q4 2024 and held it in 1 quarter.
Optiver Holding's ResMed position peaked at $33.2K in Q4 2024.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Optiver Holding's 13F filing for Q1 2025, filed 15 May 2025.